Contact No: +91-8826373757 | +91-8826859373 | 011-25052216
Email: rakesh.its@gmail.com | editor@innovativepublication.com


Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Current Issue

Year 2019

Volume: 6 , Issue: 4

Article view: 524

Article download: 184

International Journal of Pharmaceutical Chemistry and Analysis


A Validated Rp-Hplc Method for Estimation of Ciprofloxacin and Tinidazole in Tablet Dosage Form


Full Text PDF Share on Facebook Share on Twitter


Author Details : Anju Goyal*, 1, Sweety Choudhary2, Gaurav Deep Singh3

Volume : 2, Issue : 1, Year : 2015

Article Page : 22-27


Suggest article by email

Abstract

 A simple, specific, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for estimation of ciprofloxacin and tinidazole in combined tablet dosage form. The separation was carried out by Inertsil C18(250Х4.6mm) column with mobile phase phosphate buffers (pH 6.8): acetonitrile (82:18) v/v, at a flow rate of 1.0ml/min. Detection was carried out at 316nm.The retention time of ciprofloxacin and tinidazole was found to be 5.6 and 9.82 min, respectively. The method was validated for linearity, accuracy and precision. Linearity for ciprofloxacin and tinidazole were in the range of 27.5 - 82.5μg/ml for ciprofloxacin, and 33μg/ml - 66μg/ml for tinidazole and the correlation coefficient was found to be 0.9999 for both the drugs. The mean recovery for ciprofloxacin and tinidazole was found to be 99.7 and 100.4. The developed method could be employed for the routine analysis of ciprofloxacin and tinidazole in combine tablet dosage form.

 

Keywords: RP-HPLC, Ciprofloxacin hydrochloride, tinidazole, specificity, linearity, precision.

How to cite : Goyal* A, 1, Choudhary2 S, Singh3 G D, A Validated Rp-Hplc Method for Estimation of Ciprofloxacin and Tinidazole in Tablet Dosage Form. Int J Pharm Chem Anal 2015;2(1):22-27

Copyright © 2015 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)